Shifting Focus to Research Services, Knome Offers Whole-Genome Sequencing, Interpretation for $5K | GenomeWeb

By Julia Karow

Human genome sequencing and analysis firm Knome, which launched in 2007 offering whole-genome sequencing directly to consumers, has shifted its focus to the more lucrative research services market.

Last week, the privately held company disclosed in a filing with the US Securities and Exchange Commission that it has raised $5 million in an equity financing round that has a target of $20 million.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Browse our free articles
You can still register for access to our free content.